Skip Header

15 results for author:"Al-Mohanna F." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (7)

Loss of ERLIN2 function leads to juvenile primary lateral sclerosis.

Al-Saif A., Bohlega S., Al-Mohanna F.

Ann. Neurol. 72:510-516(2012) · Mapped (1)

POC1A truncation mutation causes a ciliopathy in humans characterized by primordial dwarfism.

Shaheen R., Faqeih E., Shamseldin H.E., Noche R.R., Sunker A., Alshammari M.J., Al-Sheddi T., Adly N., Al-Dosari M.S., Megason S.G. et al.

Am. J. Hum. Genet. 91:330-336(2012) · UniProtKB (2) · Mapped (3)

Partner in fat metabolism: role of KLFs in fat burning and reproductive behavior.

Hashmi S., Zhang J., Siddiqui S.S., Parhar R.S., Bakheet R., Al-Mohanna F.

3 Biotech 1:59-72(2011) · Mapped (2)

A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis.

Al-Saif A., Al-Mohanna F., Bohlega S.

Ann. Neurol. 70:913-919(2011) · UniProtKB (1)

Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma.

Raef H., Al-Rijjal R., Al-Shehri S., Zou M., Al-Mana H., Baitei E.Y., Parhar R.S., Al-Mohanna F.A., Shi Y.

J. Clin. Endocrinol. Metab. 95:1000-1006(2010) · Mapped (9)

A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease.

Elhawari S., Al-Boudari O., Muiya P., Khalak H., Andres E., Al-Shahid M., Al-Dosari M., Meyer B.F., Al-Mohanna F., Dzimiri N.

Atherosclerosis 209:152-154(2010) · Mapped (2)

Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.

Alsmadi O., Muiya P., Khalak H., Al-Saud H., Meyer B.F., Al-Mohanna F., Alshahid M., Dzimiri N.

Ann. Hum. Genet. 73:475-483(2009) · Mapped (5)

Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.

DeNiro M., Alsmadi O., Al-Mohanna F.

Exp. Eye Res. 89:700-717(2009) · Mapped (9)

RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth.

Al-Ahmadi W., Al-Haj L., Al-Mohanna F.A., Silverman R.H., Khabar K.S.

Oncogene 28:1782-1791(2009) · Mapped (6)

Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.

Zou M., Baitei E.Y., Alzahrani A.S., Al-Mohanna F., Farid N.R., Meyer B., Shi Y.

Neoplasia 11:57-65(2009) · Mapped (3)

Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome.

Alazami A.M., Al-Saif A., Al-Semari A., Bohlega S., Zlitni S., Alzahrani F., Bavi P., Kaya N., Colak D., Khalak H. et al.

Am. J. Hum. Genet. 83:684-691(2008) · UniProtKB (2) · Mapped (2)

The interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease.

Abu-Amero K.K., Al-Mohanna F., Al-Boudari O.M., Mohamed G.H., Dzimiri N.

BMC Med. Genet. 8:35-35(2007) · Mapped (9)

Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma.

Zou M., Famulski K.S., Parhar R.S., Baitei E., Al-Mohanna F.A., Farid N.R., Shi Y.

J. Clin. Endocrinol. Metab. 89:6146-6154(2004) · Mapped (2)

RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR.

Khabar K.S., Siddiqui Y.M., al-Zoghaibi F., al-Haj L., Dhalla M., Zhou A., Dong B., Whitmore M., Paranjape J., Al-Ahdal M.N. et al.

J. Biol. Chem. 278:20124-20132(2003) · Mapped (4)

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.

Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., Collinson K., Zhu A., Stern E., Saido T. et al.

Nature 389:689-695(1997) · UniProtKB (2) · Mapped (2)

to top of page·

Page 1 of 1